Intellectual Property India Publishes Patent Application for 'Heterocyclic Sik Inhibitors' Filed by Pfizer Inc.

MUMBAI, India, March 28 -- Intellectual Property India has published a patent application (202517021520 A) filed by Pfizer Inc., New York, on March 10, for 'heterocyclic sik inhibitors.'

Inventor(s) include Bootsma Andrea Nicole; Ebner David Christopher; Kung Daniel Wei Shung; Perry Matthew Alexander; Schmitt Daniel Copley; Strohbach Joseph Walter; and Thorarensen Atli.

The application for the patent was published on March 28, under issue no. 13/2025.

According to the abstract released by the Intellectual Property India: "A compound of formula (I) having the structure: or a pharmaceutically acceptable salt thereof as SIK inhibitor wherein A1 and A2 are independently O or S; X is selected from CH2 CD2 NR3 O and S where R3 is selected from...